-
My Account
My Account
You are Here : Moneycontrol Markets IPO Glenmark Life Sciences
Description They are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, They have established strong relationships with leading global generic pharmaceutical companies that have helped us expand Their product offerings and geographic reach. They work with 16 .... More »
Address Plot No. 170-172 Chandramouli, Industrial Est.Mohol Bazarpeth, Solapur Maharashtra , India. Pincode : 413213
| As on Date | QIB | NII | RII | EMP | Total |
|---|---|---|---|---|---|
| 28-Jul-2021 00:00 | 0.98 | 0.87 | 4.61 | 2.78 | |
| 27-Jul-2021 00:00 | 0.00 | 0.26 | 2.85 | 1.49 |
| Issue price / Floor Price (Rs) | 695.00-720.00 |
| Application per share (Rs) | 720.00 |
| Minimum investment amount (Rs) | 14,400.00 |
| Minimum bid (no of shares) | 20 |
| Maximum Shares for Retail | N.A. |
| Issue opens | 27-Jul-21 |
| Issue closes | 29-Jul-21 |
| Listing on | BSE NSE |
| Issue size (Rs cr) | 1497.85 - 1513. |
| Mkt cap at issue price (Rs cr) | N.A. |
| Lead Manager |
|---|
| Kotak Mahindra Capital Company Limited | gls.ipo@kotak.com |
| BofA Securities India Limited | dg.glenmark_ipo@bofa.com |
| Registrar | KFin Technologies Private Limited |
| glenmark.ipo@kfintech.com |
| Shares on Offer | Lakhs |
|---|---|
| Total shares offered | N.A. |
| Of above, offered to public | N.A. |
| Post-issue shares | N.A. |
| Post-issue promoters' holding(%) | N.A. |
| Financials | Crore |
|---|---|
| No of months | N.A. |
| Turnover | N.A. |
| Net profit / (loss) | N.A. |
| Borrowings | N.A. |
| Add a comment...Whether IPO is good or bad, mad rush for every issue is resulting in listing g.. See more
Posted by : sunash
ROLLEX do it really give listing profits as automotive sector is not in good c.. See more
Posted by : prithvi23
next week will see four IPOs Devyani, Windlas, Exxaro and Krsanaa..
Posted by : sunash
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
